Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 19, 2023CNS Neuroscience & TherapeuticsOpen Access

Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis

View Full Paper
Ask AI
Bookmark
Share

Authors

CYChangwei YangSir Run Run Shaw HospitalWWWuqiong WangPDPengxi Deng

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yang et al. (2023) studied this question.

synapsesocial.com/papers/6a7c02100bfa86fad9c65ab5https://doi.org/10.1111/cns.14302
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fibroblast growth factor 21 and dietary macronutrient intake in female mice2022 · 12 citations
  2. 2Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease2019 · 119 citations
  3. 3Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease2019 · 482 citations
  4. 4Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis2018 · 214 citations
  5. 5Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease2020 · 136 citations